Led · Seed · Jun 2026

Neubond develops a forearm-worn wristband and companion app that detect faint muscle electrical signals and deliver sensory biofeedback to help rebuild neural connections after stroke. The platform was developed from over a decade of research in Imperial College London’s Neuromechanics and Rehabilitation Technology lab and was founded by Dr Patrick Sagastegui Alva and Jumpei Kashiwakura with Professor Dario Farina as a co-founder. In a 15-patient pilot, users experienced a 30% increase in range of motion after one month, and the company is running a clinical feasibility study at Charing Cross Hospital to prepare for a randomized controlled trial. Neubond raised £1.5 million in seed funding to finalise the device, pursue MHRA certification, and support its clinical programme. The company is positioning its regulatory and commercial approach toward NHS adoption and exploring broader applications of its neural interface in areas like exoskeleton control.

Participated · Series A · Sep 2025

Nanofiber Quantum Technologies (NanoQT) is a quantum-hardware company focused on building nanofiber cavity-QED interconnects that seamlessly integrate with neutral-atom quantum processing units (QPUs). These ultra-low-loss interconnects are designed to enable scalable, modular, and networked quantum computers while remaining compatible with quantum communication infrastructure. The firm is headquartered in Palo Alto, California, and operates engineering and manufacturing sites in College Park, Maryland, and Tokyo, Japan. To date, NanoQT has benefited from more than US$20 million in government R&D grants across Japan and the United States, supporting its technical roadmap. With the new capital, the company plans to demonstrate a distributed quantum computing system that links QPUs over standard fiber, productize its interconnect technology, and scale its engineering and manufacturing capacity. Management is led by CEO and co-founder Masashi Hirose, Ph.D., who is steering a global commercialization strategy that leverages both U.S. and Japanese ecosystems.

Participated · Seed · Mar 2024

Blue Laser Fusion develops a proprietary laser fusion system that pairs a high-efficiency megajoule pulse-energy laser with a fast repetition rate and a high-gain, aneutronic solid fuel target to achieve commercial fusion. The company positions its technology as a complete clean energy system for providing electrical power to homes, businesses, and electric vehicles. Blue Laser Fusion closed a $37.5M Seed funding round. Backers in the round included SoftBank Corp., Yusaku Maezawa through the Maezawa Fund, Itochu Corporation, JAFCO Group Co., Ltd., SPARX Group Co., Ltd. (Mirai Creation Fund III), and Waseda University Ventures. Founded in 2022 and based in Palo Alto, CA, the company was co-founded by Nobel Laureate Shuji Nakamura, Hiroaki Ohta, and Richard Ogawa. BLF plans to complete its first prototype in 2025 and to demonstrate a commercial-ready fusion reactor by 2030. Blue Laser Fusion is developing a proprietary laser fusion technology using HB11 fuel aimed at accelerating the transition to a carbon-free electrified world. Its laser enables Mega Joule pulse energy with a fast repetition rate to achieve commercial fusion, and the company holds over 200 claims in patent applications. The company recently raised $25M in initial Seed funding to support R&D and prototype development. Founded in 2022 by Shuji Nakamura (President and CEO), Hiroaki Ohta, and Richard Ogawa, the company is based in California. Blue Laser Fusion intends to use the funds to expand R&D operations in the Santa Barbara area and Tokyo to develop its prototype commercial reactor. It plans to complete its first prototype in 2025 and to demonstrate a commercial-ready fusion reactor by 2030. The company aims to create a complete clean energy system to supply electric power to homes, businesses and electric vehicles.